Temporomandibular Joint Disorder (TMJD) is a condition that affects the jaw joint and the muscles controlling jaw movement, leading to pain, discomfort, and limited jaw function. At Regenamex, we offer an innovative and advanced treatment option using Expanded Wharton’s Jelly Mesenchymal Stem Cells (WJ-MSCs) to address TMJD and provide relief at a cellular level. Our dedicated medical team aims to harness the powerful regenerative properties of WJ-MSCs to improve symptoms and enhance the quality of life for patients living with TMJD.
Wharton’s Jelly, found in the umbilical cord, is an abundant source of potent Mesenchymal Stem Cells. These Expanded WJ-MSCs possess remarkable regenerative capabilities that can be beneficial in managing TMJD. When introduced into the affected area, WJ-MSCs have the potential to repair damaged tissues and promote tissue regeneration, leading to pain reduction and improved jaw function.
TMJD often involves inflammation of the jaw joint and surrounding tissues. WJ-MSCs have the unique ability to interact with the immune system and other cells involved in the inflammatory response. By modulating the immune response and reducing inflammation, WJ-MSC therapy targets the underlying inflammatory processes that contribute to pain and discomfort in TMJD.
In addition to their regenerative and anti-inflammatory properties, WJ-MSCs offer neuroprotective benefits. TMJD can lead to nerve sensitivity and pain. The release of growth factors and other neuroprotective factors by WJ-MSCs can help protect nerve cells from further damage and support their recovery, potentially leading to reduced pain and improved nerve function.
By promoting tissue repair, providing pain relief, and protecting nerves at a cellular level, WJ-MSC therapy offers the potential for significant improvement in symptoms and an enhanced quality of life for patients with TMJD. The reduction in inflammation, enhanced tissue healing, and neuroprotection may lead to decreased pain intensity, increased jaw mobility, and an overall improvement in physical and emotional well-being.
At Regenamex, our treatment approach is tailored to each patient’s specific needs. The Expanded Wharton’s Jelly Mesenchymal Stem Cells are sourced from carefully screened and ethically obtained umbilical cords. The treatment plan is customized to optimize potential benefits for individual patients, ensuring the most effective and personalized care.
WJ-MSC therapy represents an innovative and safe option for managing TMJD. The procedure is minimally invasive, and WJ-MSCs have shown a favorable safety profile in clinical trials. Compared to traditional approaches, which may involve long-term use of medications with potential side effects, WJ-MSC therapy offers a potentially safer and more targeted solution.
At Regenamex, we are committed to providing cutting-edge treatments for TMJD, and our use of Expanded Wharton’s Jelly Mesenchymal Stem Cells is at the forefront of regenerative medicine. By leveraging the regenerative, anti-inflammatory, and neuroprotective properties of WJ-MSCs at a cellular level, we aim to offer lasting pain relief and improved jaw function for patients living with Temporomandibular Joint Disorder. Our experienced medical team is dedicated to delivering personalized and innovative care to bring hope and healing to those coping with the challenges of TMJD.
Our programs offer a legal option that allows you to get the treatment you need for a fraction of the price in the US and Canada.
